1. Home
  2. MAIA vs PHUN Comparison

MAIA vs PHUN Comparison

Compare MAIA & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.23

Market Cap

44.9M

Sector

Health Care

ML Signal

HOLD

Logo Phunware Inc.

PHUN

Phunware Inc.

HOLD

Current Price

$2.14

Market Cap

55.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAIA
PHUN
Founded
2018
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
44.9M
55.9M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
MAIA
PHUN
Price
$1.23
$2.14
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$7.25
AVG Volume (30 Days)
449.7K
165.4K
Earning Date
11-07-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,357,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$73.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$1.83
52 Week High
$2.74
$6.29

Technical Indicators

Market Signals
Indicator
MAIA
PHUN
Relative Strength Index (RSI) 55.91 42.88
Support Level $1.07 $1.83
Resistance Level $1.25 $2.13
Average True Range (ATR) 0.11 0.11
MACD 0.04 0.03
Stochastic Oscillator 61.02 72.22

Price Performance

Historical Comparison
MAIA
PHUN

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.

Share on Social Networks: